GlassScriptPhysician profile
Hany M Nasr
NPI 1396872107
$3,090.65
in general payments reported to CMS, 2019-2025
21 companies · $442 in 2025
The $442 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $789 · 2020: $156 · 2021: $82.52 · 2022: $486 · 2023: $519 · 2024: $615 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,575.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $1,216.87 | 2019-2025 | Xtampza, Belbuca |
| Stimwave Technologies Incorporated | $399.55 | 2022 | |
| Scilex Pharmaceuticals INC. | $276.30 | 2019-2023 | Ztlido |
| Biodelivery Sciences International, INC. | $210.96 | 2019-2020 | |
| Nevro Corp. | $200.63 | 2019-2024 | Senza |
| Vertos Medical, INC. | $158.16 | 2024 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $138.22 | 2020-2024 | Relistor |
| Boston Scientific Corporation | $81.75 | 2019-2023 | |
| Medtronic, INC. | $64.72 | 2023-2025 | Synchromedii, Intellis Adaptivestim |
| Flowonix Medical Incorporated | $62.39 | 2019-2020 | |
| Abbott Laboratories | $48.54 | 2024 | Proclaim |
| Vertiflex, INC. | $45.06 | 2019 | |
| Painteq LLC | $39.04 | 2021 | |
| Bioventus LLC | $24.64 | 2019 | |
| Saluda Medical Americas, INC. | $22.96 | 2024 | Evoke |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $19.57 | 2019 | |
| Amgen INC. | $19.14 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $18.25 | 2025 | |
| Novartis Pharmaceuticals Corporation | $15.55 | 2019 | |
| Pernix Therapeutics Holdings, INC. | $15.05 | 2019 | |
| Lilly USA, LLC | $13.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hany Nasr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.